Lack of confirmatory data following Article 12 MRL reviews for 2,4‐d, fenhexamid and iprovalicarb

The European Commission mandated EFSA to issue a statement concerning confirmatory data that were not submitted by the set deadline by the applicant following Article 12 reviews under Regulation (EC) No 396/2005 for the following substances/commodity combination: 2,4‐d on buckwheat and other pseudo‐...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Statement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546792/
https://www.ncbi.nlm.nih.gov/pubmed/34729094
http://dx.doi.org/10.2903/j.efsa.2021.6910
Descripción
Sumario:The European Commission mandated EFSA to issue a statement concerning confirmatory data that were not submitted by the set deadline by the applicant following Article 12 reviews under Regulation (EC) No 396/2005 for the following substances/commodity combination: 2,4‐d on buckwheat and other pseudo‐cereals, fenhexamid on kiwis, iprovalicarb on lettuces, escaroles/broad‐leaved endives and roman rocket/rucola. EFSA prepared a statement containing a final conclusion on the completeness of the data necessary to support the existing tentative maximum residue levels (MRLs) and indications to risk managers whether or not the tentative MRLs currently established by Regulation (EC) No 396/2005 could be maintained. The statement was circulated to Member States for consultation via a written procedure before finalisation.

Ejemplares similares